Pharvaris (PHVS) Profit After Tax (2020 - 2026)

Pharvaris (PHVS) reported Profit After Tax of -$45.9 million for Q1 2026, up 5.85% on a YoY basis from -$43.4 million in Q1 2025, and up 15.65% quarter-over-quarter from -$54.4 million in Q4 2025.

Pharvaris (PHVS) Profit After Tax (2020 - 2026) Analysis & Trends

Pharvaris has reported Profit After Tax for 7 years, with the latest figure at -$45.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Profit After Tax rose 5.85% year-over-year to -$45.9 million; the trailing twelve-month figure through Mar 2026 stood at -$195.2 million (down 19.23% YoY), and the FY2025 full-year result was -$198.5 million, down 36.64% from the prior year.
  • Profit After Tax for Q1 2026 stood at -$45.9 million, up from -$54.4 million in the prior quarter.
  • The five-year high for Profit After Tax was -$8.6 million in Q3 2022, with the low at -$54.4 million in Q4 2025.
  • Historically, Profit After Tax has averaged -$34.0 million across 5 years, with a median of -$35.2 million in 2023.
  • Annual changes were most pronounced in 2022 — Profit After Tax increased 26.44% — and 2023, when it plunged 200.18%.
  • Pharvaris' Profit After Tax stood at -$40.0 million in 2022, then rose by 11.89% to -$35.2 million in 2023, then declined by 5.42% to -$37.1 million in 2024, then tumbled by 46.47% to -$54.4 million in 2025, then rose by 15.65% to -$45.9 million in 2026.
  • The last three Profit After Tax figures came in at -$45.9 million (Q1 2026), -$54.4 million (Q4 2025), and -$43.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -2.97 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 30.90 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -14.46 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -3.63 Mn
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -753,254.00
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 1.03 Bn
9 Abivax 90.15 Bn 90.15 Bn - -56.74 Mn
10 Pharvaris 28.66 Bn 28.37 Bn - -45.89 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -45.89 Mn
Dec 31, 2025 -54.41 Mn
Sep 30, 2025 -43.42 Mn
Jun 30, 2025 -51.48 Mn
Mar 31, 2025 -48.75 Mn
Dec 31, 2024 -37.15 Mn
Sep 30, 2024 -45.81 Mn
Jun 30, 2024 -32.02 Mn
Mar 31, 2024 -30.44 Mn
Dec 31, 2023 -35.23 Mn
Sep 30, 2023 -25.69 Mn
Jun 30, 2023 -23.85 Mn
Mar 31, 2023 -24.29 Mn
Dec 31, 2022 -39.99 Mn
Sep 30, 2022 -8.56 Mn
Jun 30, 2022 -13.47 Mn
Mar 31, 2022 -17.99 Mn
Dec 31, 2021 -14.12 Mn
Sep 30, 2021 -10.78 Mn
Jun 30, 2021 -18.31 Mn